Sylvie Lamy

1.9k total citations
32 papers, 1.6k citations indexed

About

Sylvie Lamy is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Sylvie Lamy has authored 32 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 10 papers in Oncology and 7 papers in Cancer Research. Recurrent topics in Sylvie Lamy's work include Angiogenesis and VEGF in Cancer (9 papers), Phytochemicals and Antioxidant Activities (5 papers) and Tea Polyphenols and Effects (4 papers). Sylvie Lamy is often cited by papers focused on Angiogenesis and VEGF in Cancer (9 papers), Phytochemicals and Antioxidant Activities (5 papers) and Tea Polyphenols and Effects (4 papers). Sylvie Lamy collaborates with scholars based in Canada, France and Taiwan. Sylvie Lamy's co-authors include Richard Béliveau, Denis Gingras, Borhane Annabi, Simon Lord‐Dufour, Dominique Boivin, Albert Moghrabi, Stéphane Barrette, Marie‐Paule Lachambre, David P. Labbé and Richard R. Desrosiers and has published in prestigious journals such as Journal of Biological Chemistry, Biochemistry and Biochemical Journal.

In The Last Decade

Sylvie Lamy

32 papers receiving 1.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sylvie Lamy Canada 22 717 312 281 241 235 32 1.6k
Atsuko Deguchi Japan 22 810 1.1× 253 0.8× 340 1.2× 201 0.8× 460 2.0× 36 1.7k
In‐Hye Ham South Korea 28 918 1.3× 141 0.5× 406 1.4× 425 1.8× 146 0.6× 83 1.9k
Bu Young Choi South Korea 27 1.3k 1.8× 208 0.7× 446 1.6× 335 1.4× 361 1.5× 56 2.6k
Jung‐Il Chae South Korea 29 1.3k 1.8× 124 0.4× 250 0.9× 208 0.9× 189 0.8× 84 2.1k
Francesca Tosetti Italy 23 1.1k 1.5× 149 0.5× 502 1.8× 339 1.4× 137 0.6× 48 2.0k
Young‐Rae Lee South Korea 27 1.0k 1.4× 121 0.4× 215 0.8× 342 1.4× 160 0.7× 81 2.1k
Elmar Krause Germany 30 1.4k 2.0× 260 0.8× 295 1.0× 197 0.8× 161 0.7× 94 2.8k
Daniela D’Arcangelo Italy 24 933 1.3× 124 0.4× 254 0.9× 245 1.0× 136 0.6× 46 1.9k
Michela Giuliano Italy 28 952 1.3× 148 0.5× 393 1.4× 297 1.2× 89 0.4× 84 1.9k
Marianna Lauricella Italy 28 1.3k 1.9× 157 0.5× 311 1.1× 379 1.6× 119 0.5× 80 2.1k

Countries citing papers authored by Sylvie Lamy

Since Specialization
Citations

This map shows the geographic impact of Sylvie Lamy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sylvie Lamy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sylvie Lamy more than expected).

Fields of papers citing papers by Sylvie Lamy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sylvie Lamy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sylvie Lamy. The network helps show where Sylvie Lamy may publish in the future.

Co-authorship network of co-authors of Sylvie Lamy

This figure shows the co-authorship network connecting the top 25 collaborators of Sylvie Lamy. A scholar is included among the top collaborators of Sylvie Lamy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sylvie Lamy. Sylvie Lamy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lamy, Sylvie, et al.. (2019). Targeting Ovarian Cancer Cell Cytotoxic Drug Resistance Phenotype with Xanthium strumarium L. Extract. Evidence-based Complementary and Alternative Medicine. 2019. 1–13. 8 indexed citations
2.
Bourgault, Steve, et al.. (2018). Biophysical evidence for differential gallated green tea catechins binding to membrane type-1 matrix metalloproteinase and its interactors. Biophysical Chemistry. 234. 34–41. 17 indexed citations
4.
Lamy, Sylvie, et al.. (2016). Anthocyanidins inhibit epithelial–mesenchymal transition through a TGFβ/Smad2 signaling pathway in glioblastoma cells. Molecular Carcinogenesis. 56(3). 1088–1099. 46 indexed citations
5.
Lamy, Sylvie, et al.. (2015). Olive oil compounds inhibit the paracrine regulation of TNF-α-induced endothelial cell migration through reduced glioblastoma cell cyclooxygenase-2 expression. The Journal of Nutritional Biochemistry. 27. 136–145. 39 indexed citations
6.
Lamy, Sylvie, et al.. (2014). Biphasic effects of luteolin on interleukin-1β-induced cyclooxygenase-2 expression in glioblastoma cells. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1853(1). 126–135. 35 indexed citations
9.
Lamy, Sylvie, et al.. (2013). Olive oil compounds inhibit vascular endothelial growth factor receptor-2 phosphorylation. Experimental Cell Research. 322(1). 89–98. 54 indexed citations
10.
Lamy, Sylvie, et al.. (2012). Diet-derived polyphenols inhibit angiogenesis by modulating the interleukin-6/STAT3 pathway. Experimental Cell Research. 318(13). 1586–1596. 52 indexed citations
11.
Lamy, Sylvie, Marie‐Paule Lachambre, Simon Lord‐Dufour, & Richard Béliveau. (2010). Propranolol suppresses angiogenesis in vitro: Inhibition of proliferation, migration, and differentiation of endothelial cells. Vascular Pharmacology. 53(5-6). 200–208. 138 indexed citations
12.
Labbé, David P., et al.. (2009). The Flavonols Quercetin, Kaempferol, and Myricetin Inhibit Hepatocyte Growth Factor-Induced Medulloblastoma Cell Migration. Journal of Nutrition. 139(4). 646–652. 78 indexed citations
13.
Lamy, Sylvie, Édith Beaulieu, David P. Labbé, et al.. (2008). Delphinidin, a dietary anthocyanidin, inhibits platelet-derived growth factor ligand/receptor (PDGF/PDGFR) signaling. Carcinogenesis. 29(5). 1033–1041. 46 indexed citations
14.
Lamy, Sylvie, et al.. (2006). Anthocyanidins inhibit migration of glioblastoma cells: Structure‐activity relationship and involvement of the plasminolytic system. Journal of Cellular Biochemistry. 100(1). 100–111. 56 indexed citations
16.
Lamy, Sylvie, Jonathan Michaud‐Levesque, Yves Durocher, et al.. (2005). Delphinidin, a dietary anthocyanidin, inhibits vascular endothelial growth factor receptor-2 phosphorylation. Carcinogenesis. 27(5). 989–996. 118 indexed citations
17.
Lamy, Sylvie, Marcia T. Ruiz, Jan Wiśniewski, et al.. (2005). A prostate secretory protein94‐derived synthetic peptide PCK3145 inhibits VEGF signalling in endothelial cells: Implication in tumor angiogenesis. International Journal of Cancer. 118(9). 2350–2358. 25 indexed citations
18.
Demeule, Michel, Jonathan Michaud‐Levesque, Borhane Annabi, et al.. (2002). Green Tea Catechins as Novel Antitumor and Antiangiogenic Compounds. PubMed. 2(4). 441–463. 105 indexed citations
19.
Lamy, Sylvie, et al.. (1999). Regulation of Rho protein binding to membranes by rhoGDI: inhibition of releasing activity by physiological ionic conditions. Biochemistry and Cell Biology. 77(1). 59–69. 2 indexed citations
20.
Gingras, Denis, France Gauthier, Sylvie Lamy, Richard R. Desrosiers, & Richard Béliveau. (1998). Localization of RhoA GTPase to Endothelial Caveolae-Enriched Membrane Domains. Biochemical and Biophysical Research Communications. 247(3). 888–893. 93 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026